Stryker SYK Vascular — Net Sales

Other product segments

Similar metrics at other companies

BSXInterventional Cardiology & Vascular Therapies — Net Sales

$1.24B+10.7%

BSXInterventional Cardiology & Vascular Therapies — Net Sales

$1.16B+10.5%

POS

POSTNut butters — Net Sales

$101.3M+392%

POS

POSTPet Food — Net Sales

$346.7M-19.9%

OTISService sales — Net Sales

$2.58B+11.3%

CENTPet — Net Sales

$476.84M+5.1%

FAQ

What is Stryker's vascular — net sales?

Stryker (SYK) reported vascular — net sales of $517M in Q1 2026.

How has Stryker's vascular — net sales changed year-over-year?

Stryker's vascular — net sales increased by 27.3% year-over-year, from $406M to $517M.

What is the long-term trend for Stryker's vascular — net sales?

Over 4 years (2021 to 2025), Stryker's vascular — net sales has grown at a 13.4% compound annual growth rate (CAGR), from $1.19B to $1.97B.

What does vascular — net sales mean?

This metric represents the total revenue generated from the sale of neurovascular products, including embolic coils, stents, and related interventional devices used to treat stroke and other vascular conditions. It serves as a key indicator of the company's market penetration and growth within the specialized neurovascular intervention space. This segment is a critical driver of high-margin medical technology revenue and reflects the company's competitive standing against other major medical device manufacturers in the neurology sector.